Time optimal control studies on COVID-19 incorporating adverse events of the antiviral drugs (Q2076182)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Time optimal control studies on COVID-19 incorporating adverse events of the antiviral drugs |
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Time optimal control studies on COVID-19 incorporating adverse events of the antiviral drugs |
scientific article |
Statements
Time optimal control studies on COVID-19 incorporating adverse events of the antiviral drugs (English)
0 references
18 February 2022
0 references
COVID-19
0 references
first line drugs
0 references
second line drugs
0 references
adverse events
0 references
time optimal control problem
0 references
bang-bang control
0 references
0 references
0 references
0 references
0 references
